Zimbabwe - English - Medicines Control Authority

varichem pharmaceuticals (pvt) ltd - rifampicin - capsule; oral - 150mg

United States - English - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - rifampin (unii: vjt6j7r4tr) (rifampin - unii:vjt6j7r4tr), isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l), pyrazinamide (unii: 2kni5n06ti) (pyrazinamide - unii:2kni5n06ti) - rifampin 120 mg - rifater is indicated in the initial phase of the short-course treatment of pulmonary tuberculosis. during this phase, which should last 2 months, rifater should be administered on a daily, continuous basis (see dosage and administration). following the initial phase and treatment with rifater, treatment should be continued with rifampin and isoniazid (e.g., rifamate) for at least 4 months. treatment should be continued for a longer period of time if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is hiv positive. in the treatment of tuberculosis, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. bacteriologic smears or cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to r

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - isoniazid; pyrazinamide; rifampicin - tablet - 50 /300 /120 milligram(s) - combinations of drugs for treatment of tuberculosis; rifampicin, pyrazinamide and isoniazid

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - pyrazinamide; rifampicin; isoniazid - oral tablet - 300mg ; 120mg ; 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - pyrazinamide; rifampicin; isoniazid - oral tablet - 300mg ; 120mg ; 50mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

navana pharmaceuticals ltd. - rifamycin - dr tablet - 194 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - pyrazinamide; rifampicin; isoniazid - oral tablet - 300mg ; 120mg ; 50mg

Canada - English - Health Canada

sanofi-aventis canada inc - rifampin; isoniazid; pyrazinamide - tablet - 120mg; 50mg; 300mg - rifampin 120mg; isoniazid 50mg; pyrazinamide 300mg - antituberculosis agents

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - isoniazid 50mg; pyrazinamide 300mg; rifampicin 120mg - tablet - active: isoniazid 50mg pyrazinamide 300mg rifampicin 120mg excipient: acacia aluminium hydroxide gel dried calcium stearate carmellose sodium colloidal silicon dioxide iron oxide red kaolin light magnesium oxide povidone purified talc sodium laurilsulfate sucrose titanium dioxide

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - lopinavir; ritonavir - tablet, film coated - 100mg - lopinavir 100mg; ritonavir 25mg